opinion: mrd sequencing test approval in multiple myeloma
Published 5 years ago • 78 plays • Length 0:59Download video MP4
Download video MP3
Similar videos
-
4:30
mrd testing is a reliable endpoint for the assessment of deep responses in myeloma clinical trials
-
1:26
next-generation diagnostic and prognostic approaches in multiple myeloma
-
5:18
response monitoring in multiple myeloma
-
8:42
assessing mrd in multiple myeloma
-
2:55
multiple myeloma mrd assessment
-
18:37
understanding multiple myeloma testing
-
9:25
mgus diagnosis: a step-by-step approach
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
1:37
predictors of unsustained mrd negativity in transplant-eligible patients with multiple myeloma
-
2:31
determining the optimal threshold to test mrd in multiple myeloma
-
4:22
mass spectrometry and response monitoring in multiple myeloma
-
2:09
mrd in multiple myeloma: prognosis, a clinical trial endpoint, and guiding treatment decisions
-
1:26
mrd in multiple myeloma: determining response
-
2:36
a multi-omic study to improve the diagnosis of multiple myeloma
-
4:40
management of r/r myeloma and mrd assessment
-
1:32
why it is crucial to assess response in multiple myeloma
-
3:47
using mrd to analyze the benefit of autologous sct in patients with myeloma
-
1:00
mrd as a response assessment in elderly multiple myeloma
-
0:52
mrd for multiple myeloma: is it ready for prime-time?
-
2:08
minimally invasive assessment of mrd in multiple myeloma
-
2:17
mrd: a promising biomarker in multiple myeloma